168 related articles for article (PubMed ID: 9213368)
1. Nociceptin, an endogenous ligand for the ORL1 receptor, decreases cardiac output and total peripheral resistance in the rat.
Champion HC; Czapla MA; Kadowitz PJ
Peptides; 1997; 18(5):729-32. PubMed ID: 9213368
[TBL] [Abstract][Full Text] [Related]
2. Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat.
Champion HC; Kadowitz PJ
Life Sci; 1997; 60(16):PL 241-5. PubMed ID: 9096263
[TBL] [Abstract][Full Text] [Related]
3. Nociceptin, an endogenous ligand for the ORL1 receptor, has vasodilator activity in the hindquarters vascular bed of the rat.
Czapla MA; Champion HC; Kadowitz PJ
Peptides; 1997; 18(6):793-5. PubMed ID: 9285926
[TBL] [Abstract][Full Text] [Related]
4. [Tyr1]-nociceptin, a novel nociceptin analog, decreases systemic arterial pressure by a naloxone-insensitive mechanism in the rat.
Champion HC; Kadowitz PJ
Biochem Biophys Res Commun; 1997 May; 234(2):309-12. PubMed ID: 9177265
[TBL] [Abstract][Full Text] [Related]
5. Endomorphin 1 and 2, endogenous ligands for the mu-opioid receptor, decrease cardiac output, and total peripheral resistance in the rat.
Champion HC; Zadina JE; Kastin AJ; Hackler L; Ge LJ; Kadowitz PJ
Peptides; 1997; 18(9):1393-7. PubMed ID: 9392842
[TBL] [Abstract][Full Text] [Related]
6. [Tyr1]-nociceptin has naloxone-insensitive vasodilator activity in the hindquarters vascular bed of the rat.
Champion HC; Kadowitz PJ
Life Sci; 1997; 61(26):PL 403-8. PubMed ID: 9416781
[TBL] [Abstract][Full Text] [Related]
7. Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat.
Champion HC; Pierce RL; Kadowitz PJ
Regul Pept; 1998 Nov; 78(1-3):69-74. PubMed ID: 9879748
[TBL] [Abstract][Full Text] [Related]
8. Regional hemodynamic effects of nociceptin/orphanin FQ in the anesthetized rat.
Abdelrahman AM; Pang CC
Eur J Pharmacol; 2002 Aug; 450(3):263-6. PubMed ID: 12208319
[TBL] [Abstract][Full Text] [Related]
9. Nociceptin, a novel endogenous ligand for the ORL1 receptor, has potent erectile activity in the cat.
Champion HC; Wang R; Hellstrom WJ; Kadowitz PJ
Am J Physiol; 1997 Jul; 273(1 Pt 1):E214-9. PubMed ID: 9252499
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla.
Chu X; Xu N; Li P; Mao L; Wang JQ
Brain Res; 1999 May; 829(1-2):134-42. PubMed ID: 10350539
[TBL] [Abstract][Full Text] [Related]
11. [Tyr1]-nociceptin and nociceptin have similar naloxone-insensitive erectile activity in the cat.
Champion HC; Bivalacqua TJ; Wang R; Hellstrom WJ; Kadowitz PJ
J Androl; 1998; 19(6):747-53. PubMed ID: 9876026
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular responses to microinjection of nociceptin and endomorphin-1 into the nucleus tractus solitarii in conscious rats.
Mao L; Wang JQ
Neuroscience; 2005; 132(4):1009-15. PubMed ID: 15857705
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide release mediates vasodilator responses to endomorphin 1 but not nociceptin/OFQ in the hindquarters vascular bed of the rat.
Champion HC; Bivalacqua TJ; Friedman DE; Zadina JE; Kastin AJ; Kadowitz PJ
Peptides; 1998; 19(9):1595-602. PubMed ID: 9864068
[TBL] [Abstract][Full Text] [Related]
14. Nociceptin/orphanin FQ: role in nociceptive information processing.
Yamamoto T; Nozaki-Taguchi N; Sakashita Y; Kimura S
Prog Neurobiol; 1999 Apr; 57(5):527-35. PubMed ID: 10215100
[TBL] [Abstract][Full Text] [Related]
15. Nociceptin inhibits the neurogenic vasopressor response in the pithed rat via prejunctional ORL1 receptors.
Malinowska B; Kozłowska H; Koneczny B; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):80-4. PubMed ID: 10651151
[TBL] [Abstract][Full Text] [Related]
16. [The mechanism of antiarrhythmic action of the endogenous ORL1 receptor agonist nociceptin].
Maslov LN; Krylatov AV; Lishmanov IuB; Galo G; Ma K; Stakheev DL
Eksp Klin Farmakol; 2004; 67(6):32-5. PubMed ID: 15707012
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide.
Shimohigashi Y; Hatano R; Fujita T; Nakashima R; Nose T; Sujaku T; Saigo A; Shinjo K; Nagahisa A
J Biol Chem; 1996 Sep; 271(39):23642-5. PubMed ID: 8798582
[TBL] [Abstract][Full Text] [Related]
18. Distinct effect of intracerebroventricular and intrathecal injections of nociceptin/orphanin FQ in the rat formalin test.
Wang JL; Zhu CB; Cao XD; Wu GC
Regul Pept; 1999 Feb; 79(2-3):159-63. PubMed ID: 10100930
[TBL] [Abstract][Full Text] [Related]
19. Opioid activity profiles indicate similarities between the nociceptin/orphanin FQ and opioid receptors.
Hawkinson JE; Acosta-Burruel M; Espitia SA
Eur J Pharmacol; 2000 Feb; 389(2-3):107-14. PubMed ID: 10688973
[TBL] [Abstract][Full Text] [Related]
20. Gastric acid secretion stimulated by centrally injected nociceptin in urethane-anesthetized rats.
Ishihara S; Minowa S; Tsuchiya S; Horie S; Watanabe K; Murayama T
Eur J Pharmacol; 2002 Apr; 441(1-2):105-14. PubMed ID: 12007927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
